Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Tekla Healthcare Investors

+ Add to Watchlist

HQH:US

34.8500 USD 0.1800 0.51%

As of 20:04:08 ET on 03/31/2015.

Snapshot for Tekla Healthcare Investors (HQH)

Open: 35.0000 High - Low: 35.0000 - 34.7700 Primary Exchange: New York
Volume: 97,280 52-Week Range: 23.8571 - 36.5211 Beta vs BTK: 0.8390

ETF Chart for HQH

No chart data available.
  • HQH:US 34.8500
  • 1D
  • 1M
  • 1Y
35.0300
Interactive HQH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for HQH

Tekla Healthcare Investors Fund is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.

Inception Date: 1987-04-22 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for HQH

NAV (on 2015-03-31) 33.9000
Assets (M) (on 2015-03-31) 1,237.0020
Shares out (M) 36.49
Market Cap (M) 1,271.66
% Premium 2.80
Average 52-Week % Premium -0.7648
Fund Leveraged N

Dividends for HQH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-02-26) 0.6300
Dividend Yield (ttm) 6.63%

Performance for HQH

1-Month -0.45% 1-Year +44.28%
3-Month +13.08% 3-Year +39.76%
Year To Date +12.64% 5-Year +32.68%
Expense Ratio 1.13

Top Fund Holdings for HQH

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,039,942 78,151,641 10.619%
Celgene Corp 706,182 59,658,255 8.106%
Regeneron Pharmaceuticals Inc 178,740 49,196,398 6.685%
Biogen Inc 132,195 36,981,551 5.025%
Alexion Pharmaceuticals Inc 259,405 34,516,429 4.690%
Amgen Inc 286,769 32,737,549 4.448%
Actavis plc 158,892 26,693,856 3.627%
Vertex Pharmaceuticals Inc 346,735 25,762,411 3.501%
Perrigo Co PLC 154,896 23,770,340 3.230%
iShares Nasdaq Biotechnology E 97,826 22,212,372 3.018%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil